“…Our results compare favourably to others who report the outcome of intrauterine transfusions using various other routes (including but not limited to; intravascular and intracardiac) at early gestations (less than 22 weeks) [1,3,5,7,[9][10][11]. In contrast with intravascular transfusions at less than 20 weeks gestation, we suggest that the intraperitoneal route is a safer and more effective method of managing these cases, although we appreciate the rarity of these cases prevents our study reaching statistical significance.…”
Section: Commentsupporting
confidence: 78%
“…Our approach to treatment is based on the understanding that fetuses with established hydrops are less likely to respond to transfusion than non-hydropic ones [6]. Early studies of intraperitoneal transfusion [7], including Liley's original description of the technique [8], reported worse outcomes once the fetus had developed hydrops due to their inability to absorb the donor blood into their circulation. We believe that initiating transfusion prior to signs of hydrops is key to successful treatment.…”
“…Our results compare favourably to others who report the outcome of intrauterine transfusions using various other routes (including but not limited to; intravascular and intracardiac) at early gestations (less than 22 weeks) [1,3,5,7,[9][10][11]. In contrast with intravascular transfusions at less than 20 weeks gestation, we suggest that the intraperitoneal route is a safer and more effective method of managing these cases, although we appreciate the rarity of these cases prevents our study reaching statistical significance.…”
Section: Commentsupporting
confidence: 78%
“…Our approach to treatment is based on the understanding that fetuses with established hydrops are less likely to respond to transfusion than non-hydropic ones [6]. Early studies of intraperitoneal transfusion [7], including Liley's original description of the technique [8], reported worse outcomes once the fetus had developed hydrops due to their inability to absorb the donor blood into their circulation. We believe that initiating transfusion prior to signs of hydrops is key to successful treatment.…”
“…IUT into the intrahepatic portion of the umbilical vein was first described by Nicolini et al [6] in 1990, and it can be a safe alternative for umbilical cord transfusion in particular in case of a posterior placenta [7]. In the Netherlands, IUT was introduced in 1965 by Bennebroek Gravenhorst et al [8]. From 1987 onwards, the intravascular technique became the method of choice [9].…”
Fetal anemia is a serious complication in pregnancy and associated with perinatal mortality and morbidity. During 25 years of worldwide experience with intravascular intrauterine blood transfusion, a variety of indications have been described. Intrauterine transfusion (IUT) treatment is considered most successful for fetal anemia due to red cell alloimmunization. Moreover, the use of this procedure has also been reported in pregnancies with parvovirus B19 infection, fetomaternal hemorrhage and placental chorioangiomas, for example. This review focuses on the current indications of intrauterine blood transfusions. In addition, we describe the potential complications of IUT treatment.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.